根据初始实证治疗对呼吸机相关肺炎 (VAP) 的十年评估:使用真实世界的数据进行回顾性分析
Alejandro Rodríguez1,2,3,4, Julen Berrueta1,5, Carolina Páez6
1Intensive Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain.
Biomedicines
|February 26, 2025
概括
呼吸机相关肺炎 (VAP) 死亡率在十年内下降,尽管病因稳定,抗生素治疗率不适当. 实施呼吸系统综合征小组可能会进一步减少VAP死亡.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 呼吸系统医学 呼吸系统医学
背景情况:
- 呼吸机相关肺炎 (VAP) 是重症监护室 (ICU) 中医院感染,死亡和发病的主要原因.
- 了解VAP结果和风险因素的趋势对于改善患者护理至关重要.
研究的目的:
- 在10年的时间内调查VAP患者的粗ICU死亡率的变化.
- 为了确定VAP死亡率的相关风险因素.
- 评估VAP病因的变化以及不适当的经验性抗生素治疗 (IEAT) 的发生率/影响.
主要方法:
- 一项回顾性,单一中心的观察性研究包括从2014年到2024年患有VAP的重症患者.
- 患者被分为COVID-19前 (2014-2018),COVID-19 (2019-2021) 和COVID-19后 (2022-2024) 的时间段.
- 二元逻辑回归分析了与ICU死亡率相关的变量.
主要成果:
- 对VAP的粗ICU死亡率为33.6%,IEAT病例的死亡率更高 (40%与33.3%相比).
- 在接受适当的经验性抗生素治疗 (AEAT) 的患者中,在研究期间 (p < 0.001) 观察到原始死亡率的显著下降,从42.2%降至22.2%.
- 死亡的独立风险因素包括老年和COVID-19期间;保护因素包括较高的平均动脉压和呼吸系统综合征面板的使用.
结论:
- 在过去的十年中,原始VAP死亡率下降,但微生物病因或IEAT率没有显著变化.
- 使用呼吸系统综合征面板与VAP死亡风险降低有关.
- 使用呼吸系统综合征面板实施协议可能是进一步降低VAP相关死亡率的策略.
相关概念视频
Pneumonia IV: Management
286
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
286
Pneumonia I: Introduction
201
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
201
Pneumonia V: Nursing management and Prevention
1.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.8K
Pneumonia III: Complications and Assessment
143
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
143
Acute Respiratory Failure-V
113
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
113
Pulmonary Tuberculosis V
165
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
165


